Investinor Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 24
- Investments
- 178
- Portfolio
- 69
- Exits
- 48
Investinor General Information
Description
Founded in 2008, Investinor is a venture capital firm based in Trondheim, Norway. The firm seeks to invest in startups, pre-seed, seed-stage, growth companies, and venture funds focused on the information technology, oil and gas, environment, energy, marine, biotech, and aquaculture sectors.
Contact Information
Website
www.investinor.no
Year Founded
2008
Investor Status
Actively Seeking New Investments
Trade Association
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Other Investor Types
Fund of Funds
Government
Growth/Expansion
Primary Office
- Brattørkaia 17B
- 7010 Trondheim
- Norway
+47 957 00 000
Investinor Investments (178)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Rayvn | 01-Feb-2022 | Later Stage VC | Media and Information Services (B2B) | Generating Revenue | 0000 0000000 | |
| 0000000 | 15-Nov-2021 | 00000 00000 | 00.000 | Systems and Information Management | Generating Revenue | 0000000 0000000 |
| 00000000 00000 | 03-Nov-2021 | 00000 00000 | 000.00 | Other Equipment | Generating Revenue | |
| 000000 000 | 28-Oct-2021 | 00000 00000 | 0000 | Forestry Processing | Generating Revenue | 0000 00000000 00.0 |
| 00000 | 17-Aug-2021 | 00000 00000 | 000 | Business/Productivity Software | Generating Revenue | 0000 0000 |
| 000000 | 14-Jul-2021 | 00000 00000 | 00000 | Media and Information Services (B2B) | Generating Revenue | |
| 0000 | 12-Jul-2021 | 00000 00000 | 00.000 | Business/Productivity Software | Generating Revenue | |
| 00000000 (00000000 | 05-Jul-2021 | 0000000000 | Therapeutic Devices | Generating Revenue/Not Profitable | 000000 00000-0000 | |
| Nomono | 02-Jul-2021 | Seed Round | 00.00 | Electronic Equipment and Instruments | Generating Revenue | Ø000000 00000 |
| Hubro Therapeutics | 01-Jul-2021 | Early Stage VC | 00.000 | Pharmaceuticals | Pre-Clinical Trials |
Investinor Exits (48)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Stimline | 01-Oct-2021 | Secondary Transaction - Private | |
| 0000000 | 01-Sep-2021 | 000000000000000000 | |
| 00000000000 | 24-Jun-2021 | 000000000000000000 | |
| 0000000 (00000 000 | 19-May-2021 | 000 00 00000000 | |
| 000000 0000000 | 26-Apr-2021 | 000 | |
| 00000000 | 22-Apr-2021 | 000000000000000000 | 00000 |
| 000000 | 02-Apr-2021 | 000000000000000000 | |
| 00000 | 18-Dec-2020 | 000 | 000.00 |
| Skitude Holding | 18-Dec-2020 | IPO | 000.00 |
| Play Magnus | 08-Oct-2020 | IPO | 000.00 |
Investinor Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialInvestinor Team (57)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Terje Eidesmo Ph.D | Chief Executive Officer | 0 | 0 | Trondheim, Norway | |
| Tor Helmersen | Chief Financial Officer | Trondheim, Norway | |||
| Lars Appelkvist | Controller | Trondheim, Norway | |||
| Ronny Vikdal | Investment Director | 0 | 0 | 0 | Trondheim, Norway |
| Ann-Tove Kongsnes | Investment Director | 00 | 0 | 0 | Trondheim, Norway |
Investinor Co-Investors (126)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Sintef Venture | 6 | 0 |
|
|
|
| TRK Group | 0 | 0 | 0 |
|
|
| Alliance Venture | 0 | 0 | 0 |
|
|
| Momentum Partners (Norway) | 0 | 0 |
|
|
|
| Sarsia Seed | 0 | 0 |
|
|